ANTIMICROBIAL ACTIVITIES OF CLAVULANIC ACID/TICARCILLIN AGAINST CLINICAL ISOLATES
In order to investigate antimicrobial activities of clavulanic acid/ticarcillin (CVA/TIPC) against Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa in 1992 and 1994, β-lactamase activities were analyzed and minimum inhibitory concentrations (MICs) were determined including those of the...
Gespeichert in:
Veröffentlicht in: | Japanese journal of antibiotics 1995/12/25, Vol.48(12), pp.1899-1905 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | jpn |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1905 |
---|---|
container_issue | 12 |
container_start_page | 1899 |
container_title | Japanese journal of antibiotics |
container_volume | 48 |
creator | KOGUCHI, MASAMI SUZUKI, YUMIKO TANAKA, SETSUKO FUKAYAMA, SHIGEMI ISHIHARA, RIKA DEGUCH, KOICHI ODA, SEIJI NAKANE, YUTAKA FUKUMOTO, TORAO |
description | In order to investigate antimicrobial activities of clavulanic acid/ticarcillin (CVA/TIPC) against Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa in 1992 and 1994, β-lactamase activities were analyzed and minimum inhibitory concentrations (MICs) were determined including those of the control drugs. The results are as follows; 1. Compared to a report in 1980, the MIC distributions of CVA/TIPC against E. coli and P. aeruginosa did not show large differences. We found, however, that CVA/TIPC-resistant strains increased among Enterobacter spp. 2. Almost all of CVA/TIPC-resistant strains of Enterobacter spp. were also resistant to cephems and new quinolones, thus they were multiple drug resistant. 3. CVA/TIPC showed strong antimicrobial activities aga inst penicillinase producing E. coli. |
doi_str_mv | 10.11553/antibiotics1968b.48.1899 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_77798829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77798829</sourcerecordid><originalsourceid>FETCH-LOGICAL-j190t-f04229364a7a95f0d084331682e5a4219f273837cc98bb6d102343f2f9c7e2cb3</originalsourceid><addsrcrecordid>eNpdkE9PwjAYhxujQYJ8BJN58TZY_2xtj3UCNqlbZIPr0o1ORwboOg5-e6sQDl7e9_A87-9NfgA8wGACYRjiqd73Tdkc-qaykEesnBA2gYzzKzBEkEV-SCi9BsMAR8xHlMFbMLa2KQMMKUMuYgAGLGQURmQI3kSSy1cZL9MnKZQn4lyuZS5nmZfOvViJ9UqJRMYOyOdpLmOxjKVSMvHEQsgky50jHXenMkuVyGfZHbipdWvN-LxHYDWf5fGLr9LFr-hvIQ96vw4IQhxHRFPNwzrYBIxgDCOGTKgJgrxGFDNMq4qzsow2MECY4BrVvKIGVSUegcdT7md3-Doa2xe7xlambfXeHI62oJRyxtyLEbg_i8dyZzbFZ9fsdPddnDtwXJ341vb63Vy47lzDrSn-110QVkD0N13pF6360F1h9vgHllR19w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77798829</pqid></control><display><type>article</type><title>ANTIMICROBIAL ACTIVITIES OF CLAVULANIC ACID/TICARCILLIN AGAINST CLINICAL ISOLATES</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>KOGUCHI, MASAMI ; SUZUKI, YUMIKO ; TANAKA, SETSUKO ; FUKAYAMA, SHIGEMI ; ISHIHARA, RIKA ; DEGUCH, KOICHI ; ODA, SEIJI ; NAKANE, YUTAKA ; FUKUMOTO, TORAO</creator><creatorcontrib>KOGUCHI, MASAMI ; SUZUKI, YUMIKO ; TANAKA, SETSUKO ; FUKAYAMA, SHIGEMI ; ISHIHARA, RIKA ; DEGUCH, KOICHI ; ODA, SEIJI ; NAKANE, YUTAKA ; FUKUMOTO, TORAO</creatorcontrib><description>In order to investigate antimicrobial activities of clavulanic acid/ticarcillin (CVA/TIPC) against Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa in 1992 and 1994, β-lactamase activities were analyzed and minimum inhibitory concentrations (MICs) were determined including those of the control drugs. The results are as follows; 1. Compared to a report in 1980, the MIC distributions of CVA/TIPC against E. coli and P. aeruginosa did not show large differences. We found, however, that CVA/TIPC-resistant strains increased among Enterobacter spp. 2. Almost all of CVA/TIPC-resistant strains of Enterobacter spp. were also resistant to cephems and new quinolones, thus they were multiple drug resistant. 3. CVA/TIPC showed strong antimicrobial activities aga inst penicillinase producing E. coli.</description><identifier>ISSN: 0368-2781</identifier><identifier>EISSN: 2186-5477</identifier><identifier>DOI: 10.11553/antibiotics1968b.48.1899</identifier><identifier>PMID: 8587164</identifier><language>jpn</language><publisher>Japan: Japan Antibiotics Research Association</publisher><subject>Bacterial Infections - microbiology ; beta-Lactamase Inhibitors ; Clavulanic Acid ; Clavulanic Acids - pharmacology ; Drug Combinations ; Drug Resistance, Microbial ; Drug Therapy, Combination - pharmacology ; Enterobacter - drug effects ; Enterobacter - isolation & purification ; Escherichia coli - drug effects ; Escherichia coli - isolation & purification ; Humans ; Penicillins - pharmacology ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - isolation & purification ; Ticarcillin - pharmacology</subject><ispartof>The Japanese Journal of Antibiotics, 1995/12/25, Vol.48(12), pp.1899-1905</ispartof><rights>Japan Antibiotics Research Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8587164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KOGUCHI, MASAMI</creatorcontrib><creatorcontrib>SUZUKI, YUMIKO</creatorcontrib><creatorcontrib>TANAKA, SETSUKO</creatorcontrib><creatorcontrib>FUKAYAMA, SHIGEMI</creatorcontrib><creatorcontrib>ISHIHARA, RIKA</creatorcontrib><creatorcontrib>DEGUCH, KOICHI</creatorcontrib><creatorcontrib>ODA, SEIJI</creatorcontrib><creatorcontrib>NAKANE, YUTAKA</creatorcontrib><creatorcontrib>FUKUMOTO, TORAO</creatorcontrib><title>ANTIMICROBIAL ACTIVITIES OF CLAVULANIC ACID/TICARCILLIN AGAINST CLINICAL ISOLATES</title><title>Japanese journal of antibiotics</title><addtitle>Jpn. J. Antibiotics</addtitle><description>In order to investigate antimicrobial activities of clavulanic acid/ticarcillin (CVA/TIPC) against Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa in 1992 and 1994, β-lactamase activities were analyzed and minimum inhibitory concentrations (MICs) were determined including those of the control drugs. The results are as follows; 1. Compared to a report in 1980, the MIC distributions of CVA/TIPC against E. coli and P. aeruginosa did not show large differences. We found, however, that CVA/TIPC-resistant strains increased among Enterobacter spp. 2. Almost all of CVA/TIPC-resistant strains of Enterobacter spp. were also resistant to cephems and new quinolones, thus they were multiple drug resistant. 3. CVA/TIPC showed strong antimicrobial activities aga inst penicillinase producing E. coli.</description><subject>Bacterial Infections - microbiology</subject><subject>beta-Lactamase Inhibitors</subject><subject>Clavulanic Acid</subject><subject>Clavulanic Acids - pharmacology</subject><subject>Drug Combinations</subject><subject>Drug Resistance, Microbial</subject><subject>Drug Therapy, Combination - pharmacology</subject><subject>Enterobacter - drug effects</subject><subject>Enterobacter - isolation & purification</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - isolation & purification</subject><subject>Humans</subject><subject>Penicillins - pharmacology</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - isolation & purification</subject><subject>Ticarcillin - pharmacology</subject><issn>0368-2781</issn><issn>2186-5477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE9PwjAYhxujQYJ8BJN58TZY_2xtj3UCNqlbZIPr0o1ORwboOg5-e6sQDl7e9_A87-9NfgA8wGACYRjiqd73Tdkc-qaykEesnBA2gYzzKzBEkEV-SCi9BsMAR8xHlMFbMLa2KQMMKUMuYgAGLGQURmQI3kSSy1cZL9MnKZQn4lyuZS5nmZfOvViJ9UqJRMYOyOdpLmOxjKVSMvHEQsgky50jHXenMkuVyGfZHbipdWvN-LxHYDWf5fGLr9LFr-hvIQ96vw4IQhxHRFPNwzrYBIxgDCOGTKgJgrxGFDNMq4qzsow2MECY4BrVvKIGVSUegcdT7md3-Doa2xe7xlambfXeHI62oJRyxtyLEbg_i8dyZzbFZ9fsdPddnDtwXJ341vb63Vy47lzDrSn-110QVkD0N13pF6360F1h9vgHllR19w</recordid><startdate>199512</startdate><enddate>199512</enddate><creator>KOGUCHI, MASAMI</creator><creator>SUZUKI, YUMIKO</creator><creator>TANAKA, SETSUKO</creator><creator>FUKAYAMA, SHIGEMI</creator><creator>ISHIHARA, RIKA</creator><creator>DEGUCH, KOICHI</creator><creator>ODA, SEIJI</creator><creator>NAKANE, YUTAKA</creator><creator>FUKUMOTO, TORAO</creator><general>Japan Antibiotics Research Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199512</creationdate><title>ANTIMICROBIAL ACTIVITIES OF CLAVULANIC ACID/TICARCILLIN AGAINST CLINICAL ISOLATES</title><author>KOGUCHI, MASAMI ; SUZUKI, YUMIKO ; TANAKA, SETSUKO ; FUKAYAMA, SHIGEMI ; ISHIHARA, RIKA ; DEGUCH, KOICHI ; ODA, SEIJI ; NAKANE, YUTAKA ; FUKUMOTO, TORAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j190t-f04229364a7a95f0d084331682e5a4219f273837cc98bb6d102343f2f9c7e2cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1995</creationdate><topic>Bacterial Infections - microbiology</topic><topic>beta-Lactamase Inhibitors</topic><topic>Clavulanic Acid</topic><topic>Clavulanic Acids - pharmacology</topic><topic>Drug Combinations</topic><topic>Drug Resistance, Microbial</topic><topic>Drug Therapy, Combination - pharmacology</topic><topic>Enterobacter - drug effects</topic><topic>Enterobacter - isolation & purification</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - isolation & purification</topic><topic>Humans</topic><topic>Penicillins - pharmacology</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - isolation & purification</topic><topic>Ticarcillin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KOGUCHI, MASAMI</creatorcontrib><creatorcontrib>SUZUKI, YUMIKO</creatorcontrib><creatorcontrib>TANAKA, SETSUKO</creatorcontrib><creatorcontrib>FUKAYAMA, SHIGEMI</creatorcontrib><creatorcontrib>ISHIHARA, RIKA</creatorcontrib><creatorcontrib>DEGUCH, KOICHI</creatorcontrib><creatorcontrib>ODA, SEIJI</creatorcontrib><creatorcontrib>NAKANE, YUTAKA</creatorcontrib><creatorcontrib>FUKUMOTO, TORAO</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KOGUCHI, MASAMI</au><au>SUZUKI, YUMIKO</au><au>TANAKA, SETSUKO</au><au>FUKAYAMA, SHIGEMI</au><au>ISHIHARA, RIKA</au><au>DEGUCH, KOICHI</au><au>ODA, SEIJI</au><au>NAKANE, YUTAKA</au><au>FUKUMOTO, TORAO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ANTIMICROBIAL ACTIVITIES OF CLAVULANIC ACID/TICARCILLIN AGAINST CLINICAL ISOLATES</atitle><jtitle>Japanese journal of antibiotics</jtitle><addtitle>Jpn. J. Antibiotics</addtitle><date>1995-12</date><risdate>1995</risdate><volume>48</volume><issue>12</issue><spage>1899</spage><epage>1905</epage><pages>1899-1905</pages><issn>0368-2781</issn><eissn>2186-5477</eissn><abstract>In order to investigate antimicrobial activities of clavulanic acid/ticarcillin (CVA/TIPC) against Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa in 1992 and 1994, β-lactamase activities were analyzed and minimum inhibitory concentrations (MICs) were determined including those of the control drugs. The results are as follows; 1. Compared to a report in 1980, the MIC distributions of CVA/TIPC against E. coli and P. aeruginosa did not show large differences. We found, however, that CVA/TIPC-resistant strains increased among Enterobacter spp. 2. Almost all of CVA/TIPC-resistant strains of Enterobacter spp. were also resistant to cephems and new quinolones, thus they were multiple drug resistant. 3. CVA/TIPC showed strong antimicrobial activities aga inst penicillinase producing E. coli.</abstract><cop>Japan</cop><pub>Japan Antibiotics Research Association</pub><pmid>8587164</pmid><doi>10.11553/antibiotics1968b.48.1899</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0368-2781 |
ispartof | The Japanese Journal of Antibiotics, 1995/12/25, Vol.48(12), pp.1899-1905 |
issn | 0368-2781 2186-5477 |
language | jpn |
recordid | cdi_proquest_miscellaneous_77798829 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Bacterial Infections - microbiology beta-Lactamase Inhibitors Clavulanic Acid Clavulanic Acids - pharmacology Drug Combinations Drug Resistance, Microbial Drug Therapy, Combination - pharmacology Enterobacter - drug effects Enterobacter - isolation & purification Escherichia coli - drug effects Escherichia coli - isolation & purification Humans Penicillins - pharmacology Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - isolation & purification Ticarcillin - pharmacology |
title | ANTIMICROBIAL ACTIVITIES OF CLAVULANIC ACID/TICARCILLIN AGAINST CLINICAL ISOLATES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A27%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ANTIMICROBIAL%20ACTIVITIES%20OF%20CLAVULANIC%20ACID/TICARCILLIN%20AGAINST%20CLINICAL%20ISOLATES&rft.jtitle=Japanese%20journal%20of%20antibiotics&rft.au=KOGUCHI,%20MASAMI&rft.date=1995-12&rft.volume=48&rft.issue=12&rft.spage=1899&rft.epage=1905&rft.pages=1899-1905&rft.issn=0368-2781&rft.eissn=2186-5477&rft_id=info:doi/10.11553/antibiotics1968b.48.1899&rft_dat=%3Cproquest_pubme%3E77798829%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77798829&rft_id=info:pmid/8587164&rfr_iscdi=true |